Which Patients can have ICL Surgery?
Proven Track Record
Over 15 years of research and development has made the Visian ICL a leader in phakic IOL technology. There have been over 300,000 Visian ICL implants performed worldwide. And when asked about the procedure, over 99% of the patients were highly satisfied.
Wide Treatment Range
The Visian ICL has proven to be effective in patients within a wide range of refractive errors. In fact, the Visian ICL can correct myopia from as low as -3.0 diopters to -16.0 diopters and reduce myopia from -16.0 diopters up to as high as -20.0 diopters with or without astigmatism. Before now, some of these individuals were not candidates for surgical vision correction. Clinical studies have shown how the Visian ICL is truly a breakthrough myopia treatment in terms of vision correction results. Because implantation of the phakic IOL does not require any structural alteration of the eye, results are predictable, very stable and reversible.